SANA

Sana Biotechnology, Inc.

8.27 USD
-0.01 (-0.18%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Sana Biotechnology, Inc. stock is up 51.19% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 3 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 2 PUTs, 8 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
15 Feb 19:10 15 Mar, 2024 7.50 PUT 500 19
15 Feb 19:16 15 Mar, 2024 10.00 CALL 249 5
15 Feb 19:32 19 Apr, 2024 10.00 CALL 200 125
15 Feb 19:39 15 Mar, 2024 10.00 CALL 375 5
15 Feb 19:39 19 Apr, 2024 10.00 CALL 200 125
15 Feb 19:45 15 Mar, 2024 7.50 PUT 500 19
20 Feb 20:25 15 Mar, 2024 5.00 CALL 144 307
21 Feb 15:40 15 Mar, 2024 7.50 CALL 350 164
23 Feb 14:35 15 Mar, 2024 10.00 CALL 595 4235
23 Feb 14:42 15 Mar, 2024 10.00 CALL 405 4235

About Sana Biotechnology, Inc.

Sana Biotechnology, Inc. focuses on utilizing engineered cells as medicines. Its product candidates include SG295 and SG242 that target CD19+ cancer cells, including non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia. SC291, a CD19 allogeneic T cell therapy; SC255 for multiple myeloma; SC451 for type I diabetes mellitus. SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, and Huntington's disease.